Target intelligence / Profile preview

RNA component of mitochondrial RNA processing endoribonuclease (RMRP)

Target
RMRP
Molecular classification
Long non-coding RNA (lncRNA), Ribonucleoprotein complex component, Other
01

Overview

The RNA component of mitochondrial RNA processing endoribonuclease (RMRP) is a long non-coding RNA essential for cellular function[1][2][3]. It forms part of the RNase MRP ribonucleoprotein complex, which is involved in cleaving precursor ribosomal RNA (pre-rRNA) for ribosome biogenesis, and also processes mitochondrial RNA at sites critical for DNA replication[1][2][3]. RMRP interacts with telomerase reverse transcriptase to create an RNA-dependent RNA polymerase complex that generates double-stranded RNA processed into small interfering RNAs[1]. Pathogenic mutations in RMRP cause cartilage-hair hypoplasia, an inherited disorder marked by skeletal dysplasia, immunodeficiency, and cancer susceptibility[2][3]. RMRP is also aberrantly upregulated in several cancers, where it can promote proliferation and migration, partly through regulation of the AKT signaling pathway and by serving as a molecular sponge for certain tumor-suppressive microRNAs such as miR-206[4][5]. Though fundamental for RNA processing, RMRP is not a typical therapeutic target such as an enzyme or receptor, and there are currently no drugs known to directly target RMRP[1][2][3][4][5].

Other names
RMRPRRRP2NME1RNase MRP RNACHH
02

Biological functions

Ribosomal RNA processingMitochondrial RNA processingCell cycle progressionRegulation of ribosome biogenesisRegulation of signaling pathways (e.g., AKT)Regulation of microRNAs (e.g., acts as a molecular sponge)
03

Disease associations

Cartilage-hair hypoplasia (CHH)Cancer (multiple types, acts as oncogene)Immunodeficiency syndromes
04

Safety considerations

Mutations are associated with multi-system genetic disorders (CHH)Potential connection to cancer progression and poor outcomes
05

Biomarkers

Prognostic biomarker in various cancers (increased RMRP expression correlates with poor prognosis)

Beyond the preview

Go deeper on RNA component of mitochondrial RNA processing endoribonuclease (RMRP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA component of mitochondrial RNA processing endoribonuclease (RMRP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call